Cystic fibrosis (CF) is a tough condition that affects over 160, 000 people worldwide. The good news is that survival rates have improved thanks to better care and new medicines. However, treating CF is expensive, so understanding the costs is crucial. A recent study looked at the costs of outpatient care for CF in big pediatric centers in the United States and Ireland. The goal was to see how different care structures affect these costs.

The study focused on three age groups: babies up to 11 months, kids aged 1 to 5 years, and young teens aged 6 to 17 years. Care teams in both countries mapped out the care process for each age group. They then measured the costs of outpatient care, especially routine clinic visits, using a method called time-driven activity-based costing (TDABC). This method calculates the cost of each resource used during a patient's care cycle.

In the United States, doctors and dietitians spent the most time with patients. In Ireland, nurse specialists and dietitians were the main caregivers. The study found that the cost of clinical visits varied the most for the 6- to 17-year-old group. In this age group, the biggest cost differences came from how long patients spent with caregivers, the types of caregivers involved, and the pay rates for these caregivers.

The study used TDABC and variance analysis to compare costs between the two countries. This approach provides a detailed look at how costs add up and how resources are used. Understanding these details can help improve care and manage costs better. However, it's important to note that the sample size was small, with only 58 patients included in the analysis. This could affect the reliability of the findings. Additionally, the study did not account for differences in healthcare systems and funding between the two countries, which could also impact costs.

The study shows that comparing costs across different healthcare settings can reveal important insights. For instance, it highlights how different care structures can lead to different costs. However, to get a full picture, future studies should consider a wider range of factors, including the unique aspects of each healthcare system. This way, the findings can be more useful for improving care and managing costs in different settings.

Cystic Fibrosis Care: Costs and Care Across the Atlantic

Actions